Page last updated: 2024-08-21

megestrol acetate and Carcinoma in Situ

megestrol acetate has been researched along with Carcinoma in Situ in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Christianson, MS; Cordeiro Mitchell, CN; Garbose, RA; Gornet, ME; Hunkler, KF; Maher, JY; Whiting-Collins, LJ1
Edman, CD; Forney, JP; Gal, D; Vellios, F1

Other Studies

2 other study(ies) available for megestrol acetate and Carcinoma in Situ

ArticleYear
Conservatively treated endometrial intraepithelial neoplasia/cancer: Risk of intrauterine synechiae.
    Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:5

    Topics: Adult; Carcinoma in Situ; Conservative Treatment; Contraceptive Agents, Female; Dilatation and Curettage; Endometrial Neoplasms; Female; Gynatresia; Humans; Hysteroscopy; Intrauterine Devices, Medicated; Levonorgestrel; Live Birth; Megestrol Acetate; Pregnancy; Pregnancy Outcome; Progestins; Retrospective Studies; Risk

2021
Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia.
    American journal of obstetrics and gynecology, 1983, Jun-01, Volume: 146, Issue:3

    Topics: Adenocarcinoma; Carcinoma in Situ; Endometrial Hyperplasia; Female; Follow-Up Studies; Humans; Megestrol; Megestrol Acetate; Menopause; Middle Aged; Time Factors; Uterine Neoplasms

1983